[
    {
        "answer": [
            "Education",
            "Healthcare",
            "Health Promotion",
            "Economic Development",
            "Natural Resource Management"
        ],
        "options": [
            "Agriculture",
            "Education",
            "Foreign Policy",
            "Healthcare",
            "Health Promotion",
            "Economic Development",
            "Environmental Protection",
            "Natural Resource Management"
        ],
        "question": "What areas do the Zapatistas wish to have autonomy in?",
        "source": {
            "isbn": "978-1264258086",
            "page": 6,
            "paragraph_id": "978-1264258086-p6-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "G protein-coupled receptors"
        ],
        "options": [
            "Ion channels",
            "Enzyme-linked receptors",
            "Nuclear hormone receptors",
            "Tyrosine kinase receptors",
            "G protein-coupled receptors",
            "Kinase receptors"
        ],
        "question": "What kinds of receptors do prostaglandins activate when they act on cells?",
        "source": {
            "isbn": "978-1264258086",
            "page": 837,
            "paragraph_id": "978-1264258086-p837-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Prostaglandin D2 (PGD2)",
            "Prostaglandin E2 (PGE2)",
            "Thromboxane A2 (TXA2)",
            "Prostaglandin F2 alpha (PGF2alpha)"
        ],
        "options": [
            "Prostaglandin D2 (PGD2)",
            "Prostaglandin E2 (PGE2)",
            "Thromboxane A2 (TXA2)",
            "Prostaglandin F2 alpha (PGF2alpha)",
            "Leukotrienes"
        ],
        "question": "What substances derived from cyclooxygenases (COX) are involved in regulating various physiological functions?",
        "source": {
            "isbn": "978-1264258086",
            "page": 842,
            "paragraph_id": "978-1264258086-p842-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "DPr1 binds to PGD2",
            "DPr2/CHRT2 binds to PGD2 and 15d-PGJ2",
            "EPr1 binds to PGE2",
            "EPr2 binds to PGE2",
            "EPr3 binds to PGE2",
            "EPr4 binds to PGE2",
            "FPr binds to PGF2\u03b1 and IsoPs",
            "IP binds to PGI2 and PGE2",
            "BLTr1 binds to LTB4",
            "BLTr2 binds to LTB4, 12(S)-HETE, 12(R)-HETE",
            "CysLTr1 binds to LTD4 and LTC4/LTE4",
            "CysLTr2 binds to LTC4/LTD4 and LTE4"
        ],
        "options": [
            "DPr1 binds to PGD2",
            "DPr2/CHRT2 binds to PGD2 and 15d-PGJ2",
            "EPr1 binds to PGE2",
            "EPr2 binds to PGE2",
            "EPr3 binds to PGE2",
            "EPr4 binds to PGE2",
            "FPr binds to PGF2\u03b1 and IsoPs",
            "IP binds to PGI2",
            "BLTr1 binds to LTB4",
            "BLTr2 binds to LTB4 and 12(S)-HETE, 12(R)-HETE",
            "CysLTr1 binds to LTD4 and LTC4/LTE4",
            "CysLTr2 binds to LTC4/LTD4"
        ],
        "question": "What ligands bind specifically to each of the following receptors: DPr1, DPr2/CHRT2, EPr1, EPr2, EPr3, EPr4, FPr, IP, BLTr1, BLTr2, CysLTr1, and CysLTr2?",
        "source": {
            "isbn": "978-1264258086",
            "page": 839,
            "paragraph_id": "978-1264258086-p839-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Absorption",
            "Distribution",
            "Metabolism",
            "Excretion"
        ],
        "options": [
            "Absorption",
            "Distribution",
            "Metabolism",
            "Excretion",
            "Toxicity"
        ],
        "question": "What are the main aspects considered under pharmacokinetics?",
        "source": {
            "isbn": "978-1264258086",
            "page": 26,
            "paragraph_id": "978-1264258086-p26-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Antisense oligonucleotides",
            "Monoclonal antibodies",
            "Enzymes",
            "Peptide hormones",
            "siRNAs",
            "Modified mRNAs"
        ],
        "options": [
            "Antisense oligonucleotides",
            "Monoclonal antibodies",
            "Enzymes",
            "Peptide hormones",
            "Small molecules",
            "Proteins",
            "siRNAs",
            "Modified mRNAs",
            "Vaccines"
        ],
        "question": "What types of large molecules are mentioned as being used therapeutically?",
        "source": {
            "isbn": "978-1264258086",
            "page": 31,
            "paragraph_id": "978-1264258086-p31-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Optimization involving med chem, crystallography, and modeling",
            "Iterations of ligand optimization guided by defining structure-activity relationships",
            "Defining structure-activity relationships followed by optimization"
        ],
        "options": [
            "Optimization involving med chem, crystallography, and modeling",
            "Experimental assay alone",
            "Iterations of ligand optimization guided by defining structure-activity relationships",
            "Only crystallography for designing new compounds",
            "Defining structure-activity relationships followed by optimization",
            "Protein-ligand docking before iterations of ligand optimization"
        ],
        "question": "What stages are involved after finding actives through experimental assays during both types of virtual screenings?",
        "source": {
            "isbn": "978-1264258086",
            "page": 30,
            "paragraph_id": "978-1264258086-p30-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Enzymes",
            "Antibodies",
            "Peptides",
            "Small molecules"
        ],
        "options": [
            "Enzymes",
            "Antibodies",
            "Peptides",
            "Small molecules",
            "Vaccines",
            "Blood products"
        ],
        "question": "What types of therapeutic agents are included in the tally of approved NMEs?",
        "source": {
            "isbn": "978-1264258086",
            "page": 38,
            "paragraph_id": "978-1264258086-p38-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Glomerular filtration",
            "Active tubular secretion",
            "Passive tubular reabsorption"
        ],
        "options": [
            "Passive tubular reabsorption",
            "Active tubular secretion",
            "Glomerular filtration",
            "Metabolic degradation"
        ],
        "question": "What are some examples of mechanisms involved in the renal excretion process?",
        "source": {
            "isbn": "978-1264258086",
            "page": 50,
            "paragraph_id": "978-1264258086-p50-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Facilitated diffusion",
            "Active transport"
        ],
        "options": [
            "Primary active transport",
            "Passive diffusion",
            "Facilitated diffusion",
            "Paracellular transport",
            "Secondary active transport",
            "Simple diffusion"
        ],
        "question": "What categories of mediated transport processes occur within cell membranes, according to how they utilize energy sources and interact with chemical gradients?",
        "source": {
            "isbn": "978-1264258086",
            "page": 44,
            "paragraph_id": "978-1264258086-p44-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Caloric content of food",
            "Volume, osmolality, temperature, and pH of ingested fluid",
            "Diurnal and interindividual variation",
            "Metabolic state (rest or exercise)",
            "Ambient temperature",
            "Effects of estrogen (specifically mentioning how it influences women differently, e.g., premenopausal vs postmenopausal status isn't detailed but acknowledging sex differences due to estrogen's role)",
            "However, since we're constrained by the instructions to follow the exact wording where applicable:",
            "Corrected Answer maintaining strict adherence would actually just reflect each item exactly as they appear without attempting to clarify or expand upon them:",
            "**Corrected Answer:**",
            "Caloric content of food",
            "Volume, osmolality, temperature, and pH of ingested fluid",
            "Diurnal and interindividual variation",
            "Metabolic state (rest or exercise)",
            "Ambient temperature",
            "The effects of estrogen"
        ],
        "options": [
            "Caloric content of food",
            "Volume, osmolality, temperature, and pH of ingested fluid",
            "Diurnal and interindividual variation",
            "Metabolic state (rest or exercise)",
            "Ambient temperature",
            "Sex due to the effects of estrogen"
        ],
        "question": "What factors influence the gastric emptying rate?",
        "source": {
            "isbn": "978-1264258086",
            "page": 46,
            "paragraph_id": "978-1264258086-p46-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Thyroxine",
            "Triiodothyronine",
            "Penicillin",
            "Phenytoin",
            "Sulfinpyrazone",
            "Bilirubin",
            "Uric acid",
            "Other NSAIDs, such as naproxen"
        ],
        "options": [
            "Thyroxine",
            "Penicillin",
            "Phenytoin",
            "Sulfinpyrazone",
            "Bilirubin",
            "Uric acid",
            "Naproxen"
        ],
        "question": "What substances do salicylates compete with for plasma protein-binding sites?",
        "source": {
            "isbn": "978-1264258086",
            "page": 857,
            "paragraph_id": "978-1264258086-p857-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Erectile dysfunction",
            "Temporary maintenance of patent ductus arteriosus in neonates",
            "Protection from NSAID-induced gastric toxicity",
            "Labor induction",
            "Pulmonary arterial hypertension",
            "Abortifacient (second trimester)",
            "Postpartum hemorrhage",
            "Ocular hypertension",
            "Open-angle glaucoma"
        ],
        "options": [
            "Erectile dysfunction",
            "Temporary maintenance of patent ductus arteriosus in neonates",
            "Protection from NSAID-induced gastric toxicity",
            "Labor induction",
            "Pulmonary arterial hypertension",
            "Abortifacient (second trimester)",
            "Postpartum hemorrhage",
            "Ocular hypertension",
            "Open-angle glaucoma"
        ],
        "question": "What therapeutic uses do prostanoids and their analogues have?",
        "source": {
            "isbn": "978-1264258086",
            "page": 845,
            "paragraph_id": "978-1264258086-p845-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "By chemical similarity"
        ],
        "options": [
            "By chemical name",
            "By molecular weight",
            "By chemical similarity",
            "By pharmacological effect"
        ],
        "question": "What types of classifications are described for categorizing NSAIDs according to chemical properties?",
        "source": {
            "isbn": "978-1264258086",
            "page": 850,
            "paragraph_id": "978-1264258086-p850-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Antimitotic effects by interfering with microtubule and spindle formation",
            "Reducing neutrophil recruitment to inflammed tissue and neutrophil adhesion",
            "Altering neutrophil motility and decreasing the secretion of chemotactic factors and superoxide anions",
            "Limiting monosodium urate crystal-induced NLRP3 inflammasome activation",
            "Increasing the sensitivity to central depressants"
        ],
        "options": [
            "Antimitotic effects by interfering with microtubule and spindle formation",
            "Reducing neutrophil recruitment to inflammed tissue and neutrophil adhesion",
            "Altering neutrophil motility and decreasing the secretion of chemotactic factors and superoxide anions",
            "Limiting monosodium urate crystal-induced NLRP3 inflammasome activation",
            "Increasing the sensitivity to central depressants"
        ],
        "question": "What are the mechanisms of action through which colchicine exerts its effects?",
        "source": {
            "isbn": "978-1264258086",
            "page": 867,
            "paragraph_id": "978-1264258086-p867-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Ibuprofen",
            "Ketoprofen",
            "Tolmetin",
            "Fenoprofen",
            "Flurbiprofen",
            "Ketoralac",
            "Oxaprozin",
            "Tiaprofenic acid",
            "Naproxen",
            "Diflunisal",
            "Meclofenamate",
            "Piroxicam",
            "Sulfinpyrazone",
            "Diclofenac",
            "Indomethacin",
            "Sulindac"
        ],
        "options": [
            "Ibuprofen",
            "Ketoprofen",
            "Tolmetin",
            "Fenoprofen",
            "Flurbiprofen",
            "Ketoralac",
            "Oxaprozin",
            "Tiaprofenic acid",
            "Naproxen",
            "Celecoxib",
            "Diflunisal",
            "Meclofenamate",
            "Piroxicam",
            "Sulfinpyrazone",
            "Diclofenac",
            "Indomethacin",
            "Sulindac",
            "Acetaminophen"
        ],
        "question": "What are the names of some of the medications categorized under Nonsteroidal Anti-Inflammatory Drugs?",
        "source": {
            "isbn": "978-1264258086",
            "page": 861,
            "paragraph_id": "978-1264258086-p861-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "H1 receptors",
            "H2 receptors",
            "H3 receptors",
            "H4 receptors"
        ],
        "options": [
            "H1 receptors",
            "H2 receptors",
            "H3 receptors",
            "H4 receptors"
        ],
        "question": "What types of receptors does histamine act upon?",
        "source": {
            "isbn": "978-1264258086",
            "page": 876,
            "paragraph_id": "978-1264258086-p876-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Endocrine factor",
            "Paracrine factor",
            "Autocrine factor",
            "Juxtacrine factor"
        ],
        "options": [
            "Endocrine factor",
            "Paracrine factor",
            "Autocrine factor",
            "Juxtacrine factor",
            "Hormonal factor"
        ],
        "question": "What types of intercellular signaling molecules are recognized?",
        "source": {
            "isbn": "978-1264258086",
            "page": 64,
            "paragraph_id": "978-1264258086-p64-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Ligand-gated ion channels",
            "Nuclear receptors",
            "Enzyme-linked (catalytic) receptors",
            "Still other cell-surface membrane receptors",
            "GPCRs"
        ],
        "options": [
            "Ligand-gated ion channels",
            "Nuclear receptors",
            "Enzyme-linked (catalytic) receptors",
            "Cell surface membrane receptors",
            "Voltage-gated ion channels"
        ],
        "question": "What types of cellular receptors are included in Table 3-1?",
        "source": {
            "isbn": "978-1264258086",
            "page": 75,
            "paragraph_id": "978-1264258086-p75-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Second messengers",
            "G protein-gated ion channels",
            "Monomeric G protein RhoA"
        ],
        "options": [
            "Second messengers",
            "Voltage-gated calcium channels",
            "Potassium channels",
            "Other signaling pathways"
        ],
        "question": "What forms of signaling are regulated by GPCRs through G proteins?",
        "source": {
            "isbn": "978-1264258086",
            "page": 81,
            "paragraph_id": "978-1264258086-p81-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Full agonists",
            "Partial agonists",
            "Neutral antagonists",
            "Inverse agonists"
        ],
        "options": [
            "Full agonists",
            "Partial agonists",
            "Neutral antagonists",
            "Inverse agonists",
            "Hormones",
            "Antigens",
            "Antibodies",
            "Other unspecified compounds"
        ],
        "question": "What types of substances act upon receptors according to the discussion about molecular mechanisms of drug action?",
        "source": {
            "isbn": "978-1264258086",
            "page": 65,
            "paragraph_id": "978-1264258086-p65-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Muscle tremor",
            "Tachycardia",
            "Palpitations",
            "Hypokalemia",
            "Ventilation-perfusion mismatch",
            "Metabolic effects"
        ],
        "options": [
            "Muscle cramp",
            "Tachycardia",
            "Metabolic disturbances",
            "Restlessness",
            "Anaphylaxis"
        ],
        "question": "What side effects result from the stimulation of extrapulmonary \u03b2 receptors caused by unwanted effects related to \u03b22 agonists?",
        "source": {
            "isbn": "978-1264258086",
            "page": 899,
            "paragraph_id": "978-1264258086-p899-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Aldesleukin",
            "Pegylated IFN-\u03b1",
            "Sargramostim",
            "Oprelvekin",
            "Erythropoietin"
        ],
        "options": [
            "Aldesleukin",
            "Pegylated IFN-\u03b1",
            "Sargramostim",
            "Oprelvekin",
            "Erythropoietin",
            "Dupilumab",
            "NOS",
            "L-arginine",
            "Citrulline",
            "NO",
            "Smad7",
            "Smad4"
        ],
        "question": "What are the names of some cytokines clinically employed and utilizing JAK-STAT pathways?",
        "source": {
            "isbn": "978-1264258086",
            "page": 85,
            "paragraph_id": "978-1264258086-p85-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Decreased uptake or excretion at clearance organs",
            "Increased uptake or decreased efflux at target organs",
            "Altered transport of endogenous compounds at target organs"
        ],
        "options": [
            "Increased uptake or increased efflux at clearance organs",
            "Decreased uptake or excretion at target organs",
            "Altered transport of exogenous compounds at clearance organs",
            "Increased uptake or decreased efflux at target organs",
            "Altered transport of endogenous compounds at target organs"
        ],
        "question": "What are the main classifications of transporter-mediated adverse drug responses?",
        "source": {
            "isbn": "978-1264258086",
            "page": 100,
            "paragraph_id": "978-1264258086-p100-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "P-Glycoprotein (Pgp)",
            "Organic Cation Transporters (OCTs)",
            "Multidrug Resistance-Associated Protein (MRP)",
            "Breast Cancer Resistance Protein (BCRP)",
            "Multi-drug And Toxin Extrusion Proteins (MATEs)"
        ],
        "options": [
            "Organic Anion Transporting Polypeptides (OATPs)",
            "Multidrug Resistance-Associated Protein (MRP)",
            "Breast Cancer Resistance Protein (BCRP)",
            "P-Glycoprotein (Pgp)",
            "Organic Cation Transporters (OCTs)",
            "Multi-drug And Toxin Extrusion Proteins (MATEs)"
        ],
        "question": "What types of transporters are specifically mentioned as examples influencing pharmacokinetic processes?",
        "source": {
            "isbn": "978-1264258086",
            "page": 101,
            "paragraph_id": "978-1264258086-p101-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Monoclonal antibodies targeting TNF-\u03b1",
            "Antibodies blocking IL-4 and IL-13",
            "Anti\u2013IL-5 and anti\u2013IL-5 receptor (IL-5R\u03b1) blocking antibodies",
            "Omalizumab (anti-IgE)"
        ],
        "options": [
            "Monoclonal antibodies targeting TNF-\u03b1",
            "Antibodies blocking IL-4 and IL-13",
            "Anti\u2013IL-5 and anti\u2013IL-5 receptor (IL-5R\u03b1) blocking antibodies",
            "Omalizumab (anti-IgE)"
        ],
        "question": "What kinds of biologic therapies are being used or researched for the treatment of asthma?",
        "source": {
            "isbn": "978-1264258086",
            "page": 909,
            "paragraph_id": "978-1264258086-p909-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Corticosteroids",
            "Vasoactive intestinal polypeptide analogues",
            "Bitter taste receptor agonists",
            "Potassium channel openers",
            "Magnesium sulfate",
            "Phosphodiesterase inhibition therapy",
            "Adenosine receptors antagonism",
            "Theophylline"
        ],
        "options": [
            "Corticosteroids",
            "Vasoactive intestinal polypeptide analogues",
            "Bitter taste receptor agonists",
            "Potassium channel openers",
            "Magnesium sulfate",
            "Phosphodiesterase inhibition therapy",
            "Adenosine receptors antagonism",
            "Theophylline"
        ],
        "question": "What types of drugs or therapies are commonly used for managing asthma and other respiratory conditions?",
        "source": {
            "isbn": "978-1264258086",
            "page": 904,
            "paragraph_id": "978-1264258086-p904-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Absorption in the small intestine",
            "Barrier function in brain capillaries",
            "Hepatobiliary elimination in the liver",
            "Tubular secretion in the kidneys"
        ],
        "options": [
            "Absorption in the small intestine",
            "Barrier function in brain capillaries",
            "Hepatobiliary elimination in the liver",
            "Tubular secretion in the kidneys"
        ],
        "question": "What are key roles played by transport mechanisms across different body parts?",
        "source": {
            "isbn": "978-1264258086",
            "page": 105,
            "paragraph_id": "978-1264258086-p105-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Erythropoietin-Stimulating Agents (ESAs)",
            "Granulocyte Colony-Stimulating Factors (GCSFs)",
            "Thrombopoietin Receptor Agonists (TRAs)"
        ],
        "options": [
            "Erythropoietin-Stimulating Agents (ESAs)",
            "Granulocyte Colony-Stimulating Factors (GCSFs)",
            "Thrombopoietin Receptor Agonists (TRAs)",
            "Interferons",
            "Corticosteroids"
        ],
        "question": "What types of agents stimulate production, maturation, and activation of various blood cells, according to their primary functions described in drug therapies for hematopoiesis?",
        "source": {
            "isbn": "978-1264258086",
            "page": 936,
            "paragraph_id": "978-1264258086-p936-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Anemia due to reduced hemoglobin production",
            "Abnormalities in heat production and metabolism",
            "Behavioral and learning problems in children"
        ],
        "options": [
            "Behavioral and cognitive issues in adults",
            "Anemia due to reduced hemoglobin production",
            "Abnormalities in heat production and metabolism",
            "Cardiovascular diseases",
            "Impaired immune function"
        ],
        "question": "What are the main ways iron deficiency can manifest in humans?",
        "source": {
            "isbn": "978-1264258086",
            "page": 926,
            "paragraph_id": "978-1264258086-p926-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Methylcobalamin",
            "Deoxyadenosylcobalamin"
        ],
        "options": [
            "Cyanocobalamin",
            "Hydroxocobalamin",
            "Methylcobalamin",
            "Methotrexate",
            "Dihydrofolate"
        ],
        "question": "What are the distinct types of vitamin B12 that play crucial roles in human metabolism according to the given information?",
        "source": {
            "isbn": "978-1264258086",
            "page": 931,
            "paragraph_id": "978-1264258086-p931-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Somatostatin Analogues",
            "Protein Tyrosine Kinase Inhibitors",
            "Dopamine Agonists",
            "Peptides",
            "Target therapies toward growth factor expression regulation"
        ],
        "options": [
            "Somatostatin Analogues",
            "Protein Tyrosine Kinase Inhibitors",
            "Dopamine Agonists",
            "Peptides",
            "Target therapies toward growth factor expression regulation",
            "Other treatments"
        ],
        "question": "What types of treatments target the somatotropic axis?",
        "source": {
            "isbn": "978-1264258086",
            "page": 947,
            "paragraph_id": "978-1264258086-p947-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Monoiodotyrosine (MIT)",
            "Diiodotyrosine (DIT)",
            "Thyroxine (T4)",
            "Triiodothyronine (T3)"
        ],
        "options": [
            "Thiocyanate",
            "Perchlorate",
            "Pendrin",
            "Sodium iodide symporter (NIS)",
            "Thyroid peroxidase",
            "Monoiodotyrosine (MIT)",
            "Diiodotyrosine (DIT)",
            "Thyroxine (T4)",
            "Triiodothyronine (T3)",
            "Megalin",
            "Lysosomal thiol endopeptidases",
            "Exopeptidases"
        ],
        "question": "What are the key substances involved in the biosynthesis pathway leading to the production of thyroid hormones?",
        "source": {
            "isbn": "978-1264258086",
            "page": 962,
            "paragraph_id": "978-1264258086-p962-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Agranulocytosis",
            "Fulminant hepatic necrosis",
            "Mild granulocytopenia",
            "Urticarial papular rash",
            "Pain and stiffness in the joints",
            "Paresthesias",
            "Headache",
            "Skin pigmentation",
            "Loss of hair"
        ],
        "options": [
            "Hepatitis",
            "Paresthesias",
            "Loss of hair",
            "Vasculitis",
            "Pain and stiffness in the joints",
            "Sore throat",
            "Fever"
        ],
        "question": "What are some adverse reactions associated with propylthiouracil and methimazole?",
        "source": {
            "isbn": "978-1264258086",
            "page": 971,
            "paragraph_id": "978-1264258086-p971-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Diethylstilbestrol",
            "Bisphenol A",
            "Genistein"
        ],
        "options": [
            "Diethylstilbestrol",
            "Bisphenol A",
            "Genistein",
            "Estrone sulfate"
        ],
        "question": "What are the names of nonsteroidal compounds with estrogenic activity listed?",
        "source": {
            "isbn": "978-1264258086",
            "page": 980,
            "paragraph_id": "978-1264258086-p980-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Suppression of FSH release",
            "Decrease in the frequency of GnRH pulses",
            "Absence of a midcycle surge of LH"
        ],
        "options": [
            "Suppression of FSH release",
            "Thickening of cervical mucus",
            "Decrease in the frequency of GnRH pulses",
            "Endometrial alteration",
            "Absence of a midcycle surge of LH"
        ],
        "question": "What mechanisms do combination oral contraceptives employ to achieve their contraceptive effect?",
        "source": {
            "isbn": "978-1264258086",
            "page": 994,
            "paragraph_id": "978-1264258086-p994-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Chemistry and Synthesis",
            "Physiological Actions",
            "Estrogen Receptors",
            "Pharmacology"
        ],
        "options": [
            "Chemistry and Synthesis",
            "Physiological Actions",
            "Pharmacology",
            "Biosynthesis",
            "Antiestrogens",
            "Therapeutic Uses",
            "Menopause and Hormone Therapy",
            "Drug Therapy in Obstetrics",
            "Endocrinology",
            "Reproduction"
        ],
        "question": "What are the different sections related to estrogens discussed within their topic?",
        "source": {
            "isbn": "978-1264258086",
            "page": 978,
            "paragraph_id": "978-1264258086-p978-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Sildenafil",
            "Vardenafil",
            "Tadalafil",
            "Avanafil"
        ],
        "options": [
            "Sildenafil",
            "Vardenafil",
            "Tadalafil",
            "Avanafil",
            "Riociguat",
            "Nitroglycerine",
            "Grapefruit Juice",
            "Alpha blockers",
            "Organic Nitrates"
        ],
        "question": "What are the names of the available PDE5 inhibitors?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1017,
            "paragraph_id": "978-1264258086-p1017-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Oral estradiol",
            "Transdermal estradiol",
            "Injectables such as estradiol valerate or estradiol cypionate"
        ],
        "options": [
            "Oral progesterone",
            "Injectable testosterones",
            "Oral estradiol",
            "Anti-androgens like finasteride",
            "Topical eflornithine",
            "Androgen gels",
            "Injectables such as estradiol valerate"
        ],
        "question": "What forms of hormones are commonly used during male-to-female transitions?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1004,
            "paragraph_id": "978-1264258086-p1004-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Deoxycorticosterone",
            "Cortisol",
            "Aldosterone",
            "Progesterone does not belong here because according to the text, progesterone acts as an antagonist rather than activating MR; however, since we're looking at activators and mentioning substances related to MR interaction:",
            "Correct Answer revised to reflect accurate representation of the information regarding substances acting upon MR:",
            "Deoxycorticosterone",
            "Cortisol",
            "Aldosterone"
        ],
        "options": [
            "Progesterone",
            "Deoxycorticosterone",
            "Cortisol",
            "Aldosterone",
            "Glucocorticoids",
            "17\u03b1-Progesterone",
            "Corticosterone",
            "Glycyrrhizic Acid"
        ],
        "question": "What substances can activate the mineralocorticoid receptor (MR)?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1028,
            "paragraph_id": "978-1264258086-p1028-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Osilodrostat",
            "Etomidate",
            "Abiraterone Acetate",
            "Mitotane",
            "Mifepristone",
            "Relacorilant"
        ],
        "options": [
            "Osilodrostat",
            "Etomidate",
            "Abiraterone Acetate",
            "Mitotane",
            "Glucocorticoid Receptor Antagonists (including Mifepristone)",
            "Relacorilant",
            "Miricorilant"
        ],
        "question": "What medications are specifically used to treat conditions associated with excessive cortisol levels, according to pharmacological treatments?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1038,
            "paragraph_id": "978-1264258086-p1038-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Anxiety disorders",
            "Insomnia",
            "Depression",
            "Peptic ulcers"
        ],
        "options": [
            "Hypogonadism",
            "Anxiety disorders",
            "Insomnia",
            "Depression",
            "Fluid retention",
            "Gout",
            "Peptic ulcers",
            "Anaphylactic shock",
            "Hypothyroidism",
            "Diabetes mellitus"
        ],
        "question": "What side effects do patients often experience while undergoing long-term glucocorticoid treatment?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1032,
            "paragraph_id": "978-1264258086-p1032-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "CYP11A1",
            "CYP11B1",
            "CYP11B2",
            "CYP17",
            "CYP17A1",
            "CYP21A2",
            "3\u03b2-HSD"
        ],
        "options": [
            "CYP11A1",
            "CYP11B1",
            "CYP11B2",
            "CYP17",
            "CYP17A1",
            "CYP21A2",
            "3\u03b2-HSD"
        ],
        "question": "What are the names of the enzymes involved in steroid hormone biosynthesis mentioned?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1024,
            "paragraph_id": "978-1264258086-p1024-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Sulfonylureas",
            "Biguanides",
            "Alpha-Glucosidase Inhibitors",
            "Thiazolidinediones",
            "GLP-1 receptor agonists",
            "Insulin"
        ],
        "options": [
            "Sulfonylureas",
            "Biguanides",
            "Alpha-Glucosidase Inhibitors",
            "Thiazolidinediones",
            "GLP-1 receptor agonists",
            "Insulin"
        ],
        "question": "What categories of pharmacological agents are commonly used in treating diabetes mellitus?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1053,
            "paragraph_id": "978-1264258086-p1053-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Skeletal muscle",
            "Liver",
            "Adipose tissue"
        ],
        "options": [
            "Skeletal muscle",
            "Liver",
            "Pancreas",
            "Brain",
            "Adipose tissue"
        ],
        "question": "What are the primary types of tissues affected by insulin resistance?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1048,
            "paragraph_id": "978-1264258086-p1048-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "\u03b1-Glucosidase Inhibitors",
            "SGLT2 Inhibitors",
            "Other Glucose-Lowering Agents",
            "Dipeptidyl Peptidase-4 (DPP-4) Inhibitors"
        ],
        "options": [
            "\u03b1-Glucosidase Inhibitors",
            "SGLT2 Inhibitors",
            "Insulin Secretagogues",
            "Other Glucose-Lowering Agents",
            "Biguanides",
            "Thiazolidinediones",
            "Sulfonylureas",
            "Meglitinides",
            "Dipeptidyl Peptidase-4 (DPP-4) Inhibitors",
            "Sodium-Glucose Cotransporter 1 (SGLT1) Inhibitors"
        ],
        "question": "What types of medications are specifically named within the discussion regarding managing type 2 diabetes?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1059,
            "paragraph_id": "978-1264258086-p1059-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Normal glucose homeostasis",
            "Impaired fasting glucose",
            "Impaired glucose tolerance",
            "Hyperglycemia diagnostic for diabetes mellitus"
        ],
        "options": [
            "Normal glucose homeostasis",
            "Impaired fasting glucose",
            "Hyperglycemia",
            "Hypoglycemia",
            "Impaired glucose tolerance"
        ],
        "question": "What are the main categories of glucose homeostasis?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1046,
            "paragraph_id": "978-1264258086-p1046-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Vitamin D2",
            "Vitamin D3"
        ],
        "options": [
            "Vitamin D alone",
            "Both vitamin D2 and vitamin D3",
            "Only vitamin D3",
            "Only vitamin D2",
            "Vitamins E and K"
        ],
        "question": "What types of vitamins D exist according to their chemical composition?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1073,
            "paragraph_id": "978-1264258086-p1073-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Metformin",
            "metformin ER"
        ],
        "options": [
            "\u03b1-Glucosidase inhibitors",
            "Dipeptidyl peptidase 4 inhibitors",
            "GLP-1 receptor agonists",
            "Meglitinides",
            "Sulfonylureas",
            "Thiazolidinediones",
            "Biguanides"
        ],
        "question": "What therapeutic agents are classified under Biguanides?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1063,
            "paragraph_id": "978-1264258086-p1063-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Burosumab",
            "Denosumab",
            "Romosozumab",
            "Raloxifene",
            "Estrogen",
            "Calcium",
            "Vitamin D",
            "Calcitriol",
            "Calcitonin",
            "Thiazide diuretics",
            "Teriparatide",
            "Abaloparatide",
            "Alendronate",
            "Pamidronate",
            "Zoledronate"
        ],
        "options": [
            "Burosumab",
            "Denosumab",
            "Romosozumab",
            "Raloxifene",
            "Estrogen",
            "Calcium",
            "Vitamin D",
            "Calcitriol",
            "Calcitonin",
            "Thiazide diuretics",
            "Teriparatide",
            "Abaloparatide",
            "Alendronate",
            "Pamidronate",
            "Zoledronate"
        ],
        "question": "What drugs are specifically mentioned as being involved in treatments related to osteoporosis?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1084,
            "paragraph_id": "978-1264258086-p1084-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Antibiotics",
            "Acid suppressors"
        ],
        "options": [
            "Antibiotics",
            "Acid suppressors",
            "Anti-inflammatory drugs",
            "Surgery",
            "Lifestyle Changes",
            "Antiviral Medications",
            "Chemotherapy",
            "Immunotherapies"
        ],
        "question": "What kinds of therapeutic approaches are commonly utilized for different gastrointestinal disorders?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1101,
            "paragraph_id": "978-1264258086-p1101-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "H2 Receptor Antagonists",
            "Proton Pump Inhibitors",
            "Potassium Competitive Acid Blockers"
        ],
        "options": [
            "Antacids",
            "Probiotics",
            "Antibiotics",
            "Anti-inflammatory Agents",
            "H2 Receptor Antagonists",
            "Potassium Competitive Acid Blockers",
            "Proton Pump Inhibitors"
        ],
        "question": "What categories of medications are commonly utilized for managing Gastric Acidity, Peptic Ulcers, and GERD?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1099,
            "paragraph_id": "978-1264258086-p1099-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Prostaglandins",
            "Mucus",
            "Bicarbonate"
        ],
        "options": [
            "Histamine",
            "Prostaglandins",
            "Bicarbonate",
            "Nitric oxide",
            "Acetylcholine",
            "Mucus"
        ],
        "question": "What types of substances are involved in protecting gastric epithelial cells from acid damage?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1093,
            "paragraph_id": "978-1264258086-p1093-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Cholinomimetics",
            "Cardiac glycosides",
            "Opioids",
            "Bromocriptine",
            "Apomorphine",
            "Emetine"
        ],
        "options": [
            "Antibiotics",
            "Cholinomimetics",
            "Cardiac glycosides",
            "Local anesthetics",
            "Opioids",
            "Benzodiazepines",
            "Bromocriptine",
            "Apomorphine",
            "Emetine"
        ],
        "question": "What types of medications can induce nausea and vomiting?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1119,
            "paragraph_id": "978-1264258086-p1119-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Loperamide",
            "Diphenoxylate",
            "Codeine",
            "Opium-containing compounds",
            "Paregoric",
            "Deodorized tincture of opium",
            "Camphorated opium tincture",
            "Morphine",
            "Racecadotril",
            "Clonidine",
            "Octreotide"
        ],
        "options": [
            "Loperamide",
            "Diphenoxylate",
            "Codeine",
            "Opium-containing compounds",
            "Paregoric",
            "Deodorized tincture of opium",
            "Camphorated opium tincture",
            "Morphine",
            "Atropine",
            "Enkephalins",
            "Racecadotril",
            "Clonidine",
            "Octreotide",
            "Somatostatin"
        ],
        "question": "What medications are specifically noted for their therapeutic uses against diarrhea?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1116,
            "paragraph_id": "978-1264258086-p1116-para1"
        },
        "type": "list"
    },
    {
        "answer": [
            "Polyethylene glycol",
            "Lactitol",
            "Sorbitol",
            "Mannitol",
            "Xylitol",
            "Maltitol",
            "Isomaltooligosaccharides",
            "Lacittol",
            "Rhamnogalacturuno-rhamnan",
            "Magnesium citrate"
        ],
        "options": [
            "Senna leaf extract",
            "Magnesium citrate",
            "Psyllium seed husk",
            "Polyethylene glycol",
            "Bisacodyl",
            "Xylitol",
            "Lacittol",
            "Rhamnogalacturuno-rhamnan"
        ],
        "question": "What are the names of the laxatives classified as osmotic?",
        "source": {
            "isbn": "978-1264258086",
            "page": 1108,
            "paragraph_id": "978-1264258086-p1108-para1"
        },
        "type": "list"
    }
]